Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05440981
NA

Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a prospective series of consecutive cases of patients undergoing iTind for the treatment of male LUTS.

Official title: The Use of Temporarily Implanted Nitinol Device (iTind) System in Chinese Male Patients With Lower Urinary Tract Symptom Secondary to Benign Prostate Enlargement

Key Details

Gender

MALE

Age Range

50 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

13

Start Date

2022-09-01

Completion Date

2025-01-21

Last Updated

2026-10-22

Healthy Volunteers

No

Interventions

DEVICE

iTind device

Cystoscopy will be performed to assess the anatomy of the bladder and prostate. The iTind device would be inserted under visual guidance into the bladder. The device will then be deployed and under visual guidance, it will be positioned at the prostatic lumen. After confirming the position of the device, cystoscopy will be withdrawn and the position will be finished.

Locations (1)

Prince of Wales Hospital

Shatin, Hong Kong